News Alert: Big Pharma Prevails in 340B Drug Discount Program

The Biden Administration is expected to appeal the decision from the Supreme Court allowing drug manufacturers to terminate sales of 340B discounted products to contracted hospital pharmacies.

The U.S. Supreme Court, in a unanimous decision, today struck down Medicare cuts to 340B hospitals, saying that the Department of Health and Human Services (HHS) did not survey participating 340B hospitals’ acquisition costs before imposing the cuts, thereby violating protections in the law against varying payment rates for certain hospitals.

By its action today, the court overturned a lower court decision that was in favor of the HHS decision.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

You May Also Like

Leave a Reply

Please log in to your account to comment on this article.

Subscribe

Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.

Resources You May Like

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’  is just $99 for a limited time! Use code WorldHealth24 at checkout.

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →